Usana Health Sciences (USNA) Net Cash Flow (2011 - 2026)

Usana Health Sciences (USNA) has reported Net Cash Flow for 16 consecutive years, with $5.2 million the latest figure, recorded in Q3 2026.

• On a quarterly basis, Net Cash Flow rose 117.14% year-over-year to $5.2 million in Q3 2026; TTM through Jul 2026 was $13.8 million, a 107.55% increase from a year earlier, with the FY2026 full-year figure at -$28.4 million, up 80.09% from the prior year.
• Net Cash Flow was $5.2 million for Q3 2026 at Usana Health Sciences, up from $3.5 million in the prior quarter.
• Over five years, Net Cash Flow peaked at $37.0 million in Q4 2022 and troughed at -$176.4 million in Q4 2024.
• A 5-year average of -$9.0 million and a median of $5.1 million in 2024 frame the typical range for Net Cash Flow.
• Across the five-year window, Net Cash Flow surged 1542.61% in 2023 and sank 1011.32% in 2024, its largest moves.
• Over 5 years, Net Cash Flow stood at $37.0 million in 2022, then sank by 47.72% to $19.4 million in 2023, then slumped by 1011.32% to -$176.4 million in 2024, then soared by 96.52% to -$6.1 million in 2025, then jumped by 185.3% to $5.2 million in 2026.
• The last three Net Cash Flow figures came in at $5.2 million (Q3 2026), $3.5 million (Q2 2026), and $11.2 million (Q1 2026), per Business Quant data.